Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| SUMMER INFAN | SUMR | 7.23% |
| NATUS MEDICA | BABY | 5.86% |
| RADIANT LOGI | RLGT | 5.85% |
| NEW ORIENTAL | EDU | 4.66% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Company Description
Konami Corp. develops and publishes video game software products for stationary and portable consoles worldwide. The company was founded in 1969 and has a market cap of $4.91 billion.
KNM was already having a great year before the company's strong Q1 results from early August supercharged shares into a new multi-year high.
First-Quarter Results
Revenue for the period was up 13% from last year to $680 million. Earnings were also up big, coming in at 36 cents, a huge gain from last year's 11 cents.
The company's biggest gains came from its smallest segment, Pachinko and Pachinki slot machines, with sales up 40% from last year. Its largest segment, Digital Entertainment, comprising almost 50% of total revenue, saw sales increase 4%.
Financial Profile
Konami has used its recent earnings momentum to strengthen its balance sheet, with cash and short-term investments up $127 million from last year to $663 million. Total debt stands at $723 million.
Estimates
We saw very bullish movement in estimates off the good quarter, with the current year adding 32 cents to $1.79 while the next-year estimate gained 35 cents to $1.97, a solid 10% growth projection.
Valuation
In light of the gains, the valuation pictures does look a bit pricey, with a PEG ratio of 2, twice the benchmark of 1 for value.
12-Month Chart
On the chart, KNM had been trading strong for most of the year before jumping higher on the good quarter in early August. Look for support from the trend line an any weakness. Take a look below.
Michael Vodicka is the Momentum Stock Strategist for Zacks.com. He is also the Editor in charge of the Zacks Momentum Trader Service.
Read the full on KNM